ROYAL BANK OF CANADA - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 38 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,000
+38.5%
11,139
+71.4%
0.00%
Q2 2023$13,0006,499
+1642.4%
0.00%
Q3 2022$0373
+2386.7%
0.00%
Q2 2022$0150.0%0.00%
Q1 2022$015
-97.0%
0.00%
Q4 2021$0
-100.0%
5000.0%0.00%
Q3 2021$1,000
-50.0%
500
-55.4%
0.00%
Q2 2021$2,000
-33.3%
1,120
+80.6%
0.00%
Q1 2021$3,000
+50.0%
620
+24.0%
0.00%
Q4 2020$2,0000.0%5000.0%0.00%
Q3 2020$2,0000.0%500
-18.0%
0.00%
Q2 2020$2,000
+100.0%
610
-7.7%
0.00%
Q1 2020$1,000
-66.7%
6610.0%0.00%
Q4 2019$3,0006610.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$3,3060.09%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$35,5840.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$183,2920.01%
MEITAV INVESTMENT HOUSE LTD 244,482$318,8280.01%
Psagot Value Holdings Ltd. / (Israel) 6,000$80.00%
IHT Wealth Management, LLC 26,800$36,7160.00%
Altshuler Shaham Ltd 12,478$17,0950.00%
Smith Salley Wealth Management 12,048$16,5060.00%
Ten Capital Wealth Advisors, LLC 1,000$1,3700.00%
BANK OF AMERICA CORP /DE/ 2,967$4,0650.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders